Scarica l'app Stockscreener
155.25
0.52%
0.81
Dopo l'orario di chiusura:
155.49
0.24
+0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$154.44
Aprire:
$154.21
Volume 24 ore:
1.59M
Relative Volume:
0.65
Capitalizzazione di mercato:
$37.06B
Reddito:
$222.29B
Utile/perdita netta:
$1.56B
Rapporto P/E:
24.22
EPS:
6.41
Flusso di cassa netto:
$2.44B
1 W Prestazione:
+1.64%
1M Prestazione:
+3.83%
6M Prestazione:
+26.77%
1 anno Prestazione:
+56.39%
Intervallo 1D:
$153.32
$155.46
Intervallo di 1 settimana:
$152.47
$155.46
Portata 52W:
$93.17
$156.44
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
155.25 | 36.92B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
721.75 | 90.05B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
292.07 | 56.87B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
69.56 | 9.21B | 12.50B | 314.00M | 421.00M | 2.44 |
|
YI
111 Inc Adr
|
8.14 | 69.56M | 2.05B | -45.99M | 5.54M | -0.5634 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Fortune 500: Here's how Central Ohio companies ranked in this year's list - The Business Journals
Cardinal Health, Inc. (NYSE:CAH) is favoured by institutional owners who hold 89% of the company - Yahoo Finance
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand | The Insight Partners - GlobeNewswire Inc.
Interesting CAH Put And Call Options For July 11th - Nasdaq
Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now - 24/7 Wall St.
Nephron Research Adjusts Cardinal Health Price Target to $166 From $160 - marketscreener.com
Baird Adjusts Price Target on Cardinal Health to $181 From $170, Maintains Outperform Rating - marketscreener.com
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook? - Yahoo Finance
Cardinal Health, Inc. (NYSE:CAH) is a favorite amongst institutional investors who own 89% - simplywall.st
Cardinal Health, Inc. (NYSE:CAH) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector? - MSN
FY2025 EPS Estimate for Cardinal Health Boosted by Analyst - Defense World
Cardinal Health ($CAH) Is Paying a $109M Settlement to Investors — Here’s How to Get Your Share - TradingView
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health stock soars to all-time high of $155 By Investing.com - Investing.com South Africa
Cardinal Health stock soars to all-time high of $155 - Investing.com Australia
Jim Cramer On Cardinal Health (CAH) “They Are Impressive” - Insider Monkey
Jim Cramer On Cardinal Health (CAH) "They Are Impressive" - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Flora Growth (FLGC), Cardinal Health (CAH) and Zevra Therapeutics (ZVRA) - The Globe and Mail
CAH Q1 Earnings Call: Cardinal Health Misses Revenue Targets but Exceeds Profit Expectations Amid Tariff Headwinds - Yahoo Finance
Cardinal Health Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Cardinal Health Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Cardinal Health Insiders Sold US$18m Of Shares Suggesting Hesitancy - Yahoo Finance
Cardinal Health (CAH) Faces Market Focus Amid Global Trade Talks - GuruFocus
Cardinal Health (CAH): Navigating Market Uncertainty | CAH Stock News - GuruFocus
JPMorgan Adjusts Cardinal Health Price Target to $156 From $145, Maintains Neutral Rating - marketscreener.com
Cardinal Health's (NYSE:CAH) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5107 - Yahoo Finance
Cardinal Health, Inc. (CAH): Among Billionaire Mason Hawkins’ Mid-Cap Stocks with Huge Upside Potential - Insider Monkey
-Charles River agrees with Elliott to add new directors, review business - marketscreener.com
Charles River to add new directors, review business in agreement with Elliott - marketscreener.com
Cardinal Health releases new report on the cell and gene therapy industry | CAH Stock News - GuruFocus
Cardinal Health releases new report on the cell and gene therapy industry - marketscreener.com
Cardinal Health (NYSE:CAH) Announces Dividend Increase to US$1 Per Share - simplywall.st
Cardinal Health Board of Directors Approves Quarterly Dividend | - GuruFocus
Cardinal Health (CAH) Boosts Quarterly Dividend and Revises Earnings Guidance - GuruFocus
Cardinal Health Raises Dividend by About 1% - MarketWatch
Cardinal Health raises quarterly dividend to $0.5107 By Investing.com - Investing.com Canada
Cardinal Health Board of Directors Approves Quarterly Dividend - GuruFocus
Cardinal Health Increases Quarterly Dividend to $0.5107 a Share From $0.5056, Payable July 15 to Investors of Record July 1 - marketscreener.com
Cardinal Health Board of Directors Approves Quarterly Dividend | CAH Stock News - GuruFocus
Cardinal Health (CAH) Stock Target Price Increased by Morgan Stanley | CAH Stock News - GuruFocus
Argus Elevates Price Target for Cardinal Health (CAH) Amid Strat - GuruFocus
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health (CAH) Price Target Increased by Morgan Stanley | - GuruFocus
Argus Adjusts Price Target on Cardinal Health to $162 From $148 - marketscreener.com
Cardinal Health’s Promising Growth Under New Leadership Justifies Buy Rating - TipRanks
Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May - Seeking Alpha
Cardinal Health Third Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):